Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine Stress MRI in Tetralogy of Fallot
NCT00564993Phase 3Terminated
- Sponsor
- Competence Network for Congenital Heart Defects
- Start
- Nov 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dobutamine in tetralogy of Fallot (TOF), Pulmonary regurgitation (PR), sponsored by Competence Network for Congenital Heart Defects. Started Nov 2007; status: terminated.
02
Drugs
dobutamine
03
Conditions
tetralogy of Fallot (TOF)Pulmonary regurgitation (PR)
Beyond the preview
Go deeper on NCT00564993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564993.